EUVIMEDEUVIMED entdecken
Crossref

MCAM+CD161− Th17 Subset Expressing CD83 Enhances Tc17 Response in Psoriasis

Kohei Maeda iD, Toshihiro Tanioka iD, Rei Takahashi iD, Hideaki Watanabe, Hirohiko Sueki iD, Masafumi Takimoto, Shin-Ichi Hashimoto, Kazuho Ikeo, Yusuke Miwa iD, Tsuyoshi Kasama iD, Sanju Iwamoto

The Journal of Immunology · 2023

DOI: 10.4049/jimmunol.2200530 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Immunology, 2023. Verfasst von Kohei Maeda und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division of Physiology and Pathology, Department of Pharmacology, Toxicology, and Therapeutics, Showa University School of Pharmacy, Tokyo, Japan. Hauptthemen laut MEDLINE: Psoriasis, Th17 Cells, Antigens, CD, Membrane Glycoproteins. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 101 Literaturangaben. Gefördert von: Japan Agency for Medical Research and Development (AMED), MEXT | Japan Society for the Promotion of Science (JSPS).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Recent studies have highlighted the pathogenic roles of IL-17–producing CD8+ T cells (T-cytotoxic 17 [Tc17]) in psoriasis. However, the underlying mechanisms of Tc17 induction remain unclear. In this study, we focused on the pathogenic subsets of Th17 and their mechanism of promotion of Tc17 responses. We determined that the pathogenic Th17-enriched fraction expressed melanoma cell adhesion molecule (MCAM) and CCR6, but not CD161, because this subset produced IL-17A abundantly and the presence of these cells in the peripheral blood of patients has been correlated with the severity of psoriasis. Intriguingly, the serial analysis of gene expression revealed that CCR6+MCAM+CD161−CD4+ T cells displayed the gene profile for adaptive immune responses, including CD83, which is an activator for CD8+ T cells. Coculture assay with or without intercellular contact between CD4+ and CD8+ T cells showed that CCR6+MCAM+CD161−CD4+ T cells induced the proliferation of CD8+ T cells in a CD83-dependent manner. However, the production of IL-17A by CD8+ T cells required exogenous IL-17A, suggesting that intercellular contact via CD83 and the production of IL-17A from activated CD4+ T cells elicit Tc17 responses. Intriguingly, the CD83 expression was enhanced in the presence of IL-15, and CD83+ cells stimulated with IL-1β, IL-23, IL-15, and IL-15Rα did not express FOXP3. Furthermore, CCR6+MCAM+CD161−CD4+ T cells expressing CD83 were increased in the peripheral blood of patients, and the CD83+ Th17-type cells accumulated in the lesional skin of psoriasis. In conclusion, pathogenic MCAM+CD161− Th17 cells may be involved in the Tc17 responses via IL-17A and CD83 in psoriasis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PsoriasisTh17 CellsAntigens, CDMembrane GlycoproteinsImmunoglobulinsHumansCD83 AntigenInterleukin-17CD8-Positive T-LymphocytesNK Cell Lectin-Like Receptor Subfamily BReceptors, CCR6MaleFemaleLymphocyte ActivationAdultMiddle AgedActivated-Leukocyte Cell Adhesion Molecule

Substanzen

CD83 AntigenAntigens, CDMembrane GlycoproteinsInterleukin-17ImmunoglobulinsNK Cell Lectin-Like Receptor Subfamily BReceptors, CCR6CCR6 protein, humanKLRB1 protein, humanIL17A protein, human

Autor:innen und Institutionen

  • Division of Physiology and Pathology, Department of Pharmacology, Toxicology, and Therapeutics, Showa University School of Pharmacy, Tokyo, Japan.
  • Department of Dermatology, Showa University School of Medicine, Tokyo, Japan.
  • Department of Pathology and Laboratory Medicine, Showa University School of Medicine, Tokyo, Japan.
  • Department of Molecular Pathophysiology, Institute of Advanced Medicine, Wakayama Medical University, Wakayama, Japan.
  • DNA Data Analysis Laboratory, National Institute of Genetics, Shizuoka, Japan.
  • Department of Internal Medicine, Division of Rheumatology, Showa University School of Medicine, Tokyo, Japan.

ORCID-Profile: Kohei Maeda, Toshihiro Tanioka, Rei Takahashi, Hirohiko Sueki, Yusuke Miwa, Tsuyoshi Kasama

Förderung

  • Japan Agency for Medical Research and Development (AMED)
  • MEXT | Japan Society for the Promotion of Science (JSPS)

Zitieren

APA

Maeda, K., Tanioka, T., Takahashi, R., Watanabe, H., Sueki, H., Takimoto, M., Hashimoto, S. I., Ikeo, K., Miwa, Y., Kasama, T., & Iwamoto, S. (2023). MCAM+CD161− Th17 Subset Expressing CD83 Enhances Tc17 Response in Psoriasis. The Journal of Immunology. https://doi.org/10.4049/jimmunol.2200530

Vancouver

Maeda K, Tanioka T, Takahashi R, Watanabe H, Sueki H, Takimoto M, et al. MCAM+CD161− Th17 Subset Expressing CD83 Enhances Tc17 Response in Psoriasis. The Journal of Immunology. 2023. doi:10.4049/jimmunol.2200530

BibTeX
@article{Maeda2023,
  author = {Maeda, Kohei and Tanioka, Toshihiro and Takahashi, Rei and Watanabe, Hideaki and Sueki, Hirohiko and Takimoto, Masafumi and Hashimoto, Shin-Ichi and Ikeo, Kazuho and Miwa, Yusuke and Kasama, Tsuyoshi and Iwamoto, Sanju},
  title = {MCAM+CD161− Th17 Subset Expressing CD83 Enhances Tc17 Response in Psoriasis},
  journal = {The Journal of Immunology},
  year = {2023},
  doi = {10.4049/jimmunol.2200530}
}
Kostenlos starten →